Member Info for Reaper007

Perhaps our two and a half trolls could move 'at pace' to another BB - obviously, regenerating, yet again via new (multiple) monikers. Otherwise the new insights, links and research from our excellent BB community read as very promising. VGLA

18.52 - hmm...

'Key is to invest when it's 'on the cusp',' This is not investment, it is trading, as all are free to decide to do.

'about to be proven (clinically) but not yet statistically proven.' -to what does this relate? I have made my views here before about our Avacta pipeline/portfolio/rollout.

'If the science/market is there then it'll happen.' - simply displays a complete lack of understanding. As ever, VGLA

I see one of our resident traders has said 'fair to assume...'. That phrase always brings to mind the one great line in a S Seagal movie - 'assumption is the mother of all f...ups. VGLA

18.35 - if what those here say about you is true, keep the wine away from your circuits. Enjoy the wine - will it be a Burgundy? VGLA

From this morning, Almostrich and B2HS2L: thank you for the information, considered posts and everything in your contributions. At present, we seem to have a well-balanced BB as I think I said yesterday; goodies and baddies with news imminent. VGLA

SeethreeIPO - apt post. Your string of posting Oct 1st still resonates. VGLA

19.20 - sums it all up. However, going forward we have 2 and a half trolls (seems about right for our BB) a grumple of complainers, derampers and, of course, the rampers. Nevertheless, our company strides forth with an amazing portfolio. Even one small part includes affimers - a global game-changer. VGLA

14.27 - I did my own research and conclude that the is a news-driven share. There is a case which can be made for chart analysis, etc in respect of appropriate stock (this is not one, imo). I note that your kaleidoscopic share comment portfolio includes a number of other shares which are not likely to adhere to the usual market analysis tools; however, each to their own. VGLA

12.50 - affirmers are yet another mega oppprtunity in our pipeline. Not go be confused with affimers - do aim to keep up(!) :-)

VGLA

Thanks Brom. VGLA

Reppst from me, Apr 19:

We do already have deals done and, clearly, there is massive scope for future deals. The AffyXell joint venture with Deawoong is one example. As I have stated here before, one of our daughters has Axial Spondyloarthritis and recently she travelled to have a consultation with a/the leading specialist for the condition. The session was very helpful and, as part of the exchange she brought out her phone with details of the AffyXell initiative. The consultant immediately responded - yes, I know of this, not quite ready for you but it will put me out of a job!

To me, this appears pretty positive about one of the elements which is already maturing within the current Avacta pipeline.

We already have 'deals' in place and I, for one, would rather see Good Deals rather than rushed, inappropriate deals. AVA6000 has has good big deal(s) potential but we already have generative arrangements in place and, imo, the most versatile resources here surround affimers. In addition, with respect to enhancement of our SP there is 'the unpredictable', involving matters like market listings, sell-offs and third party approaches, etc. etc.... So, it is clear that we have numerous avenues both 'already open' and' to explore' suggesting price action at any time, sooner rather than later. As ever, VGLA

Hi: Affyxell going strong. I might repost my earlier comment on this.....VGLA

http://www.affyxell.com/en/

14.14 - well done with views and posting and best of luck in new areas. It's a tough environment here......VGLA

I hope it is still too soon for that one. VGLA

09.24 - and if you run in shorts in the Med you can get burnt/burned/red/sore(!) VGLA

07.55 - our company faces various 'risks' amongst our numerous 'rewards'. At this stage, a low offer buyout is certainly a 'risk'. Talk has already identified parts of our portfolio which could be considered as separate units - an alternative range of options. It feels (to me) that we are sitting on a goose that is laying several golden eggs and a total buyout should be at a suitably enormous premium. For a variety of reasons we could, currently, be rather vulnerable to an opportunistic low offer. So, if you can, then keep your golden shares.....as ever, VGLA

09.27 - whatever the future holds for Avacta DX human population passed 8 billion very recently (now it is 8.108 billion). This is great news for viruses and invasive micro-organisms. The potential for 'trouble' from old foes, mutated foes, new foes, is staggering. Pop grew by 1,000 whilst I typed this (yes, I know, it is a reflection on my finger dexterity!). As ever, VGLA

09.20 - yes, for some. Definitely not for cancer sufferers. However, thanks for the great posting......VGLA

19.11 - I see this poster has just about managed to stumble along a yellow brick road back to its/her/his keyboard. Unfortunately, the post content entirely missed all available points. As ever, VGLA

13.27: makes the point. VGLA